For adult patients with moderate‑to‑severe plaque psoriasis, chronic plaque‑type atopic dermatitis, alopecia areata, or vitiligo refractory to topical therapy, phototherapy, or approved systemic agents, what are the indications, dosing regimen, required screening, monitoring schedule, contraindications, and alternative systemic options for oral tofacitinib?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 20, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What are the appropriate off‑label indications, dosing regimen, required screening, contraindications, monitoring parameters, and alternative systemic therapies for oral tofacitinib in moderate‑to‑severe plaque psoriasis, alopecia areata, vitiligo, and refractory atopic dermatitis?

What are the indications, recommended dosing, baseline and ongoing monitoring, contraindications, and alternative systemic therapies for oral tofacitinib (a Janus kinase inhibitor) in treating inflammatory skin diseases such as plaque psoriasis, alopecia areata, vitiligo, and chronic atopic dermatitis?

What are the uses and recommendations for Soquelitinib?

What is the role of Tofacitinib (Janus kinase inhibitor) in the treatment of moderate to severe plaque psoriasis in adult patients who have failed or are intolerant to other systemic therapies, including those with a history of recurrent infections or malignancies?

What is the recommended dosing of tofacitinib (Janus kinase inhibitor) for a patient with vitiligo?

In an adult who has undergone a lateral internal sphincterotomy and a trans‑sphincteric fistulotomy, does preserved continence indicate that sexual sensation is also intact, or are internal anal sphincter (IAS) pressure and sexual signaling unrelated?

What is the recommended treatment for acute and chronic paronychia, including management adjustments for patients who are diabetic, immunocompromised, or have peripheral vascular disease?

What intravenous magnesium sulfate dose and infusion schedule should be used in an adult with aluminum‑phosphide (Celphos) poisoning who develops cardiac instability or refractory hypotension, and what are the pediatric dosing recommendations?

Is there any difference between bipolar affective disorder and bipolar disorder?

What are the appropriate off‑label indications, dosing regimen, required screening, contraindications, monitoring parameters, and alternative systemic therapies for oral tofacitinib in moderate‑to‑severe plaque psoriasis, alopecia areata, vitiligo, and refractory atopic dermatitis?

In a patient with psoriasis who has joint pain, what is the role of HLA‑B27 testing and how does it influence the diagnosis and management of psoriatic arthritis, especially axial disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.